| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |